Antibiotic stewardship

Transkript

1 Herlev og Gentofte Hospital Antibiotic stewardship Erfarenheter från Köpenhamn Magnus Arpi Klinisk Mikrobiologisk afdeling Herlev og Gentofte Hospital 22. november 2016

2 Hvordan skal man måle effekten af et antibiotic stewardship program? Strategiske mål? Procesmål? Resultatmål?

3

4

5 Strong recommendations Enough data points before and after the intervention Adequate evaluation of seasonal variation requires a minimim of 24 monthly measures. Optimally 24 data points before and after the intervention A minimum of 100 observations at each time point to achieve an accetable level of variability of the estimate at each time point Ramsay et al. J Antimicrob Chemother 2003; 52:

6 Strong recommendations Interrupted times series analysis with segmented regression analysis * Estimates how much an intervention changed an outcome, immediately and over time * Comparison of the means of data before and after the intervention can either overestimate or underestimate the effect size Include a control group * Without a control group, it is impossible to say whether or not any observed differences before and after the intervention would have happened anyway Ramsay et al. J Antimicrob Chemother 2003; 52:

7 Figure 1. Graphic illustration of segmented regression analysis of interrupted time series data Craig Ramsay et al. J. Antimicrob. Chemother. 2003;52:

8 Antibiotic stewardship at Herlev Hospital

9 Consumption of cephalosporins and fluoroquinolones at Herlev Hospital DDD/1000 ocupied bed days Cephalosporins Fluoroquinolones

10 Correlation between antibiotic consumtion and og resistance 18 E. coli Cefuroxim % resistance DDD/100 occupied bed days Ciprofloxacin % resistance DDD/100 occupied bed days

11 Stevens et al. CID 2011; 53: 42-48

12 Medicinsk afdeling - Cefalosporiner DDD/1000 sengedage Cefalosporiner Mean 3SD 3SD Mål Mean = gennemsnitligt forbrug de seneste 30 måneder 3 SD = 3 standarddeviationer Mål = afdelingsspecifikt mål for antibiotikaindsatsen DDD = Daglige Definerede Døgndoser. Antibiotikaforbruget angives som DDD/1000 sengedage, som er et godt mål på antibiotikatrykket og som tillader sammenligninger mellem forskellige afdelinger og forskellige hospitaler 1. Antibiotika Audit - skriftlig rapport 2. Feed-back på audit til alle læger 3. Ændring af antibiotikavejledning

13 Antibiotic stewardship - Strategier Information alene Antibiotika audit med intervention og feedback Autorisation/klausulering

14

15

16

17 Monitoring antibiotic consumption in the Capital Region of Denmark

18

19 Cefuroxim

20 Ciprofloxacin

21 Antibiotic Coverage Bacteremia, Herlev Hospital Before 2011 After 2011 P-value Ampicillin + Gentamicin 90,7 % 92,1 % 0,13 Cefuroxime + Gentamicin 85,6 % 89,6 % <0,01 Cefuroxime + Ciprofloxacin 83,8 % 88,0 % <0,01 Cefuroxime 69,9 % 78,6 % <0,01 Ciprofloxacin 47,8 % 51,0 % 0,04 Ampicillin 41,6 % 45,1 % 0,03 Gentamicin 66,6 % 70,9 % 0,04 Piperacillin/tazobactam 96,6 % 97,1 % 0,40

22 Antibiotic coverage of empiric treatment of bacteremia at Herlev Hospital

23 Clostridium difficile

24

25 Anæstesiologisk afd. I Brystkirurgisk afd. F og Plastikkirurgisk afd. V Børneafdeling E Gastroenheden, afd. D Gynækologisk afd. G Obstetrisk afd. G Hjertemedicinsk afd. S Hud- og allergiafd. U, GE Lungemedicinsk afd. Y, GE Medicinsk hæmatologisk afd. L Medicinsk afd. C, GE Medicinsk. afd. O Nefrologisk afd. B Neurologisk afd. N Onkologisk afd. R Ortopædkirurgisk afd. T Urologisk afd. H inkl. palliation Herlev og Gentofte Hospital DDD/1000 sengedage Consumption of fluoroquinolones at Herlev and Gentofte Hospital Forbrug pr sengedage Mål 0

26 Boel et al. Eur J Clin Microbiol Infect Dis 2015; 34:

27 Appropriateness of empiric treatment Bacteremia, Herlev Hospital 2010 (n=699) 2011 (n=820) 2012 (n=843) Appropriate treatment 78.8% (551) 84.9% (696) 85.7% (722)

28 Mortality in bacteremia at Herlev Hospital 2010 (n=692) 2011 (n=792) 2012 (n=773) 30-day s mortality 21.5% (149) 20.7% (164) 17.9% (138)

29 Charlson Comorbidity Index Bacteremia, Herlev Hospital 2010 (n=692) 2011 (n=792) 2012 (n=773) Low (0) 23.0% (159) 24.9% (197) 20.0% (154) Medium (1-2) 41.9% (290) 39.4% (312) 42.8% (331) High (>2) 35.1% (243) 35.7% (283) 37.3% (288)

30 Effect on readmission All first episodes of bacteraemia (n=2008) Crude 30-day readmission HR (CI 95%) P-value Adjusted* 30-day readmission HR (CI 95%) Treatment regimen (ref. old regime) All-cause readmission 1.01 (0.87, 1.19) (0.87, 1.25) 0.24 Acute readmission 1.04 (0.87, 1.23) (0.90, 1.33) 0.38 Infection-related readmission 0.97 (0.65, 1.46) (0.67, 1.67) 0.82 Appropriate empirical treatment (ref. inappropriate treatment) All-cause readmission 0.82 (0.66, 1.01) (0.73, 1.13) 0.38 Acute readmission 0.72 (0.57, 0.91) < (0.64, 1.01) 0.06 Infection-related readmission 0.67 (0.40, 1.14) (0.44, 1.26) 0.27 P-value *Adjusted for age, sex, Charlson Comorbidity Index score, origin of infection, study year and admission to ICU by using Cox proportional hazard regression.

31

32

33 Thønnings et al. Clinical Microbiology and Infection 2016,

34 New guidelines in the Capital Region of Denmark

35 Reducere hospitalserhvervet antibiotikaresistens i Region Hovedstaden Beslutningsstøtte Indikation for behandling Standardpakker -profylakse/kirurgi -empirisk -målrettet Forbrug/indkøb (DDD) Mål: Reduktion = 10 % Dosis Behandlingsvarighed Relevant indikation før start af behandling Relevante diagnostiske prøver før behandlingsstart Administrationsform Stopdato Case-mix Feedback på adfærd Forbrugsmønster Mål: Andel penicillin = 70 % Præparatvalg/ Optimalt førstevalg Opfølgning på prøvesvar mhp skift fra empirisk til målrettet behandling Skift fra IV til PO-behandling Restriktion af udvalgte antibiotika

36

37

38 5 quality metrics for antimicrobial stewardship programmes 1. Days of therapy per 1000 patient-days 2. Number of patients with specific organisms that are drug resistant 3. Mortality related to antimicrobial-resistant organisms 4. Conservable days of therapy among patients with CAP, SSTI or BSI 5. Unplanned hospital readmission within 30 days after discharge from the hospital with the diagnosis CAP, SSTI or BSI CAP = community-acquired pneumonia SSTI = skin and soft-tissue infections BSI = bloodstream infection Morris et al. Infect Control Hosp Epidemiol 2012; 33(5):

39 Problem areas * Fear of aminoglycosides * Self-reported penicillin allergy * High consumption of penicillins with β-lactamase inhibitors

40

41 Paterson et al. J Gen Intern Med 1998; 13:

42

43 Aminoglykosider Cochraneanalyse 2014 Doseringinterval 58 studier

44 Aminoglykosider Cochraneanalyse 2014 Behandlingslængde 41 studier

45

46 Penicillin allergy DANGEROUS DIAGNOSIS!! Confirmation is mandatory

47 Penicillin allergy Borch et al. Ugeskr Læger 2003; 165/33: patients with self-reported penicillin allergy -15 patients were tested positive (13,7%) -3 patients showed systemic reactions (2,8%) Kerr JR. Br J Clin Pract 1994; 48(1): patients with self-reported penicillin allergy - 14,3% were tested positive - 1,1% (3 patients) showed type-1 allergy

48

49 Undersøgelse af penicillinallergi i Californien Macy et al. J Allergy Clin Immunol 2014; 133: * indlagte patienter med Cave penicillin (11,9 % af alle indlagte patienter) * Sammenlignes med dobbelt så stor kohorte uden Cave penicillin matchet på køn, alder, indlæggelsesdato og ICD-9 diagnoser

50 Patienter med Cave penicillin * behandles oftere med fluoroquinoloner, clindamycin og vancomycin (p<0.001) * har 23,4% flere Clostridium difficilie infektioner * har 14,1% flere MRSA påvist * har 30,1% flere VRE påvist * er indlagt 0,6 dage længere Macy et al. J Allergy Clin Immunol 2014; 133:

51 Patienter med Cave penicillin * har højere hospitalsmortalitet (OR 1,56) * ligger oftere på intensiv (OR 1,42) * får oftere kombinationsbehandling med antibiotika (OR 1,61) Charneski et al. Pharmacotherapy 2011; 31(8):

52 DDD/1000 sengedage Consumption of β-lactamase inhibitors at Herlev and Gentofte Hospital Gentofte matriklen Betalactamasehæmmere Herlev matriklen Betalactamasehæmmere

53

54 Saust et al. Scand J Prim Health Care 2016,

55 Herlev Hospital 18. novemnber 2016